IT Sector Equity Research Report January 14‚ 2011 IT-Tier 1 IT Services THEMATIC Humpty Dumpty sat on a wall… Analyst contact Ankur Rudra‚ CFA Tel: +91 22 3043 3211 ankurrudra@ambitcapital.com Tier 1 Indian IT firms have outperformed the Sensex by 14% over the last twelve months and are trading at ~20x FY12 P/E. Such share prices imply long term revenue growth rates >20% over FY11-16 and sustained margin performance. Our reverse DCF analysis indicates that this will be tough to
Premium Term Chennai Revenue
Indian Pharmaceutical Sector Analysis Contents: * Introduction * Market Size & Growth Rates * Market Segmentation * Key Players in Pharma Industry * Market Drivers * Challenges for Pharma Industry * SWOT Analysis * References Introduction Indian Pharmaceutical Industry is one of the success stories of modern India. The wide ranging capabilities in the complex field of drug manufacture & technology has established India as one of the major producer of
Premium Pharmacology Pharmaceutical industry Generic drug
Recommendations 14 5.1 Consolidate in India 14 5.2 Expanding presence in Russia 15 5.3 Withdraw R&D and Manufacturing from Germany 15 5.4 Expand into emerging markets of South Africa‚ Mexico and Japan 15 5.5 Increased focus on Collaborative Research 16 5.6 Aggressive focus on CRAMS 17 5.7 Invest early into BioSimilars 19 5.8 Expand Drug portfolio 19 5.9 Expand into patented drugs market 20 6. Implementation Schedule and Timeline 20 7. Alternatives Considered 21 8 Key Business Risks
Premium Generic drug Pharmaceutical industry
SUPPLY CHAIN SECTOR REPORT ON PHARMACEUTICAL INDUSTRY SRI SRI UNIVERSITY FACULTY OF MANAGEMENT STUDIES (2012-2014) SUBMITTED BY: Shyam Mohankar Priyansh Saxena Mrunalini Negi SUBMITTED TO: Dr.R.K .Padhy Contents 1.0 INTRODUCTION ....................................................................................................................................... 2 PHARMACEUTICAL SUPPLY CHAIN FLOW DIAGRAM .......................................................................
Premium Pharmaceutical industry Pharmacology Clinical trial
Recommends curbing gold imports to reign in current account deficit * Room to increase exports in the short run limited FOREIGN INFLOWS * Foreign Institutional Investors (FIIs) flows need to be targeted towards long-term rupee instruments SECTOR GROWTH * Industrial output seen growing around 3 pct in
Free Economics Macroeconomics Inflation
Environmentally‚ Indonesia is particularly prone to natural disasters‚ as the recent earthquakes‚ tsunamis and volcanic eruptions have illustrated. Politically‚ a dominant feature of President Yudhoyono’s presidency has been to curb the corruption that has so frequently plagued Indonesia. Economically‚ Indonesia’s economy is projected to become the sixth largest in the Asia Pacific region by 2017‚ but if the rupiah continues to devaluate against the dollar it could affect the Indonesian pharmaceutical
Premium Pharmaceutical industry Indonesia Pharmacology
b.pharma INTRODUCTION INTRODUCTION Drug Omeprazole Omeprazole is a proton pump inhibitor used in the treatment of dyspepsia‚ peptic ulcer disease (PUD)‚ gastroesophageal reflux disease (GORD/GERD)‚ laryngopharyngeal reflux (LPR)‚ and Zollinger-Ellison syndrome. It was first marketed in the US in 1989 by AstraZeneca under the brand names Losec and Prilosec‚ and is now also available from generic manufacturers under various brand names. AstraZeneca
Premium Pharmaceutical industry Sales Generic drug
Beximco Pharma Submitted to: Husna Ara Lecturer‚ Department of Business Administration East West University Submitted by: Group: 3 Name | ID | Signature | Shajia Afrin | 2011-2-30-120 | | Shahena Akter | 2011-2-30-125 | | Sadia Akter Moury | 2011-2-30-119 | | Shoha Afrin | 2011-2-30-123 | | Lutfun Nahar Diba | 2011-2-40-176 | | Date of Submission: 12-07-2011 13 July‚ 2011 To‚ HUSNA ARA Lecturer‚ Department of Business Administration‚ East West University‚
Premium Balance sheet Pharmacology Pharmaceutical drug
The industry was given its due by the successive governments in Indian Five yearplans and the industry was promoted through direct investment‚ intellectual property‚ price regulation and above all the support of scientific research. From a regulatory perspective‚ a large degree of liberalisation took place with the abolition of industrial licensing‚ 100 percent foreign direct investment‚ liberalisation of rules related to foreign technology agreements as well as of the import regime. At the same
Premium Investment Pharmacology Mumbai
Big‚ Bad Pharma: An Unnecessary Evil Big‚ Bad Pharma: An Unnecessary Evil Big Pharma‚ or the pharmaceutical industry’s giant corporations‚ have earned record profits‚ falsified clinical trial data and corrupted the healthcare industry according to many industry critics including a recent report posted on Globalresearch.ca.[1] The industry’s story parallels the history of other corporate monopolies such as Big Oil‚ the Railroad Industry‚ Big Agriculture‚ banking interests and other industrial giants
Premium Pharmacology Clinical trial Medicine